Related Experiment Video
Updated: May 17, 2026
06:38
Induction of Ocular Surface Inflammation and Collection of Involved Tissues
Published on: August 4, 2022
Interleukin-2 and autoimmune disease occurrence and therapy
European Review for Medical and Pharmacological Sciences
|November 1, 2012
Summary
Interleukin-2 (IL-2) is crucial for immune regulation. Its deletion causes autoimmune diseases, but IL-2 therapy shows potential for treating these conditions.
Area of Science:
- Immunology
- Autoimmunity
- Cellular Biology
Background:
- Interleukin-2 (IL-2), or T-cell growth factor, is produced by T cells and regulates immune responses.
- IL-2 is vital for regulatory T cell development, homeostasis, and function.
- IL-2 deficiency in vivo triggers T cell-mediated autoimmune diseases.
Purpose of the Study:
- To elucidate the mechanisms of IL-2 deletion-induced autoimmune diseases.
- To explore the therapeutic applications of IL-2 in managing autoimmune conditions.
Main Methods:
- Literature review of IL-2's role in immunity and autoimmunity.
- Analysis of IL-2's impact on T cell subsets and immune function.
- Examination of clinical data and research on IL-2-based therapies.
Main Results:
- IL-2 deficiency results in immune defects, including reduced Treg cells, impaired activation-induced cell death (AICD), and decreased cytotoxicity.
- These defects contribute to the pathogenesis of autoimmune diseases.
- Combination therapies involving IL-2 may offer benefits for immunological disorders.
Conclusions:
- IL-2 plays a critical role in preventing autoimmunity.
- Therapeutic strategies targeting IL-2 hold promise for autoimmune disease treatment.
- Controlled clinical trials are necessary to validate IL-2's efficacy in autoimmune disease therapy.
Related Concept Videos
01:24T Cell Types and Functions
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
01:29Autoimmune Disorders
Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune system...
Concept and Mechanism of Autoimmune Diseases
The immune system...
01:26Type I Diabetes II: Pathophysiology
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
01:20Inflammatory Bowel Disease II: Ulcerative Colitis
Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal BarrierA...
01:25Inflammatory Bowel Disease III: Crohn's Disease
Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...